$469 Million is the total value of NORTH TIDE CAPITAL, LLC's 13 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 75.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SEM | Sell | SELECT MED HLDGS CORP | $86,400,000 | +12.6% | 4,500,000 | -10.0% | 18.43% | +7.9% |
| MCK | Buy | MCKESSON CORP | $76,805,000 | +211.2% | 500,000 | +233.3% | 16.38% | +198.3% |
| SVU | New | SUPERVALU INC | $43,500,000 | – | 2,000,001 | +100.0% | 9.28% | – |
| MYL | Buy | MYLAN N V | $42,350,000 | +9.1% | 1,350,000 | +35.0% | 9.03% | +4.6% |
| GILD | Sell | GILEAD SCIENCES INC | $40,510,000 | -42.8% | 500,000 | -50.0% | 8.64% | -45.1% |
| ENDP | Buy | ENDO INTL PLC | $34,260,000 | +2.2% | 4,000,000 | +33.3% | 7.31% | -2.0% |
| TVTY | Sell | TIVITY HEALTH INC | $30,600,000 | -69.3% | 750,000 | -70.0% | 6.53% | -70.6% |
| PRGO | PERRIGO CO PLC | $25,395,000 | +12.1% | 300,000 | 0.0% | 5.42% | +7.4% | |
| THC | Buy | TENET HEALTHCARE CORP | $25,207,000 | +30.3% | 1,534,200 | +53.4% | 5.38% | +24.9% |
| ESRX | New | EXPRESS SCRIPTS HLDG CO | $22,162,000 | – | 350,000 | +100.0% | 4.73% | – |
| CVS | New | CVS HEALTH CORP | $20,330,000 | – | 250,000 | +100.0% | 4.34% | – |
| IVC | New | INVACARE CORP | $16,112,000 | – | 1,023,000 | +100.0% | 3.44% | – |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $5,250,000 | – | 1,000,000 | +100.0% | 1.12% | – |
| VVUS | Exit | VIVUS INC | $0 | – | -5,000,000 | -100.0% | -1.36% | – |
| BIOS | Exit | BIOSCRIP INC | $0 | – | -3,000,000 | -100.0% | -1.81% | – |
| IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -1,000,000 | -100.0% | -3.58% | – |
| SVU | Exit | SUPERVALU INC | $0 | – | -10,000,000 | -100.0% | -7.32% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SELECT MED HLDGS CORP | 18 | Q3 2017 | 22.7% |
| SUPERVALU INC | 17 | Q2 2017 | 15.0% |
| SYNERON MEDICAL LTD | 16 | Q1 2017 | 5.0% |
| HEALTHWAYS INC | 15 | Q4 2016 | 17.5% |
| KINDRED HEALTHCARE INC | 14 | Q4 2016 | 11.0% |
| ALMOST FAMILY INC | 14 | Q3 2016 | 5.9% |
| VIVUS INC | 13 | Q2 2017 | 3.3% |
| TEVA PHARMACEUTICAL INDS LTD | 12 | Q1 2016 | 13.4% |
| AMEDISYS INC | 12 | Q1 2016 | 13.2% |
| MYLAN N V | 11 | Q3 2017 | 14.0% |
View NORTH TIDE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IRIDEX CORP | February 16, 2021 | 760,069 | 5.5% |
| BioScrip, Inc.Sold out | February 01, 2018 | 0 | 0.0% |
| TIVITY HEALTH, INC. | August 02, 2017 | 450,000 | 1.1% |
| AMEDISYS INC | January 22, 2016 | 1,382,388 | 4.1% |
| HEALTHWAYS, INC | November 12, 2015 | 4,080,573 | 11.3% |
| ALMOST FAMILY INC | January 12, 2015 | 1,078,750 | 11.4% |
| VIVUS INC | January 05, 2015 | 10,150,000 | 9.8% |
| KINDRED HEALTHCARE, INC | October 10, 2014 | 3,390,000 | 5.2% |
| ORTHOFIX INTERNATIONAL N V | April 04, 2014 | 980,100 | 5.4% |
| Syneron Medical Ltd. | February 14, 2014 | 2,000,000 | 5.7% |
View NORTH TIDE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2021-02-16 |
| SC 13G/A | 2018-02-01 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| SC 13D/A | 2017-08-02 |
| 13F-HR | 2017-05-15 |
| 4 | 2017-03-20 |
| 4 | 2017-03-10 |
| 4 | 2017-03-07 |
| 4 | 2017-03-02 |
View NORTH TIDE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.